866-484-8870
  • Genomic Tests
    • Genomic Testing Overview
    • Liquid Trace®
      • Liquid Trace® Solid Tumor
      • Liquid Trace® Hematology
      • Liquid Trace® Overview
    • Solid Tumors
      • Solid Tumor Profile Plus
      • IHC Testing
      • Solid Tumor Profile
      • Solid Tumor Fusion/Expression Profile
      • Liquid Trace® Solid Tumor
    • Hematologic Tumors
      • Hematology Profile Plus
      • Hematology Profile
      • Liquid Trace® Hematology
    • Gene Tables
      • Solid Tumor DNA Genes
      • Hematology DNA Genes
      • cfDNA Genes
      • RNA & cfRNA Genes
    • What Test to Order
    • How to Order a Test
    • Interprestation™
  • Physicians
    • Why GTC
    • What Cancers We Test for
    • Cooperation
    • NGS Testing
    • AI – Machine Learning
    • Interprestation
    • Turnaround Time – TAT
    • Reducing Cancer Disparity Program
    • Publications
    • Pay Invoice
    • FAQ for Physicians
  • Patients
    • Why Testing Matters
    • Time Matters
    • Reducing Cancer Disparity Program
    • Non-Invasive Liquid Biopsy
    • What Test to Order
    • Patient Foundations
    • What is VEXAS Disease
    • Billing Information
      • Pay Bill
    • FAQ for Patients
  • Genomic Tests
    • Genomic Testing Overview
    • Liquid Trace®
      • Liquid Trace® Solid Tumor
      • Liquid Trace® Hematology
      • Liquid Trace® Overview
    • Solid Tumors
      • Solid Tumor Profile Plus
      • IHC Testing
      • Solid Tumor Profile
      • Solid Tumor Fusion/Expression Profile
      • Liquid Trace® Solid Tumor
    • Hematologic Tumors
      • Hematology Profile Plus
      • Hematology Profile
      • Liquid Trace® Hematology
    • Gene Tables
      • Solid Tumor DNA Genes
      • Hematology DNA Genes
      • cfDNA Genes
      • RNA & cfRNA Genes
    • What Test to Order
    • How to Order a Test
    • Interprestation™
  • Physicians
    • Why GTC
    • What Cancers We Test for
    • Cooperation
    • NGS Testing
    • AI – Machine Learning
    • Interprestation
    • Turnaround Time – TAT
    • Reducing Cancer Disparity Program
    • Publications
    • Pay Invoice
    • FAQ for Physicians
  • Patients
    • Why Testing Matters
    • Time Matters
    • Reducing Cancer Disparity Program
    • Non-Invasive Liquid Biopsy
    • What Test to Order
    • Patient Foundations
    • What is VEXAS Disease
    • Billing Information
      • Pay Bill
    • FAQ for Patients
Genomic Testing Cooperative Logo
Patients Results
  • About GTC
    • Client Services
    • Our Story
    • Our Team
    • Licenses & Certifications
    • CGMBS Training
    • Cooperative Model
      • How the Co-Op Works
      • The Co-Op in Action
    • International Representatives
    • Careers
    • Events
    • Investors
    • Media Kit
    • Contact Us
  • Research
    • Research & Pharma Services
    • Digital Molecular Sample Bank  
    • Biomarker Data
    • Gene Expression
    • CDx – Companion Diagnostics
    • Schedule a Consult
  • Newsroom
    • Press Releases
    • Publications
    • Events
    • Blog | Articles
    • Newsletter Subscription
    • Downloads
  • About GTC
    • Client Services
    • Our Story
    • Our Team
    • Licenses & Certifications
    • CGMBS Training
    • Cooperative Model
      • How the Co-Op Works
      • The Co-Op in Action
    • International Representatives
    • Careers
    • Events
    • Investors
    • Media Kit
    • Contact Us
  • Research
    • Research & Pharma Services
    • Digital Molecular Sample Bank  
    • Biomarker Data
    • Gene Expression
    • CDx – Companion Diagnostics
    • Schedule a Consult
  • Newsroom
    • Press Releases
    • Publications
    • Events
    • Blog | Articles
    • Newsletter Subscription
    • Downloads
Edit Content
Client Services
Patient Results
Downloads
Premium Content

Genomic Tests

  • Test Overview
  • How to Order a Test
  • What Test to Order
Liquid Biopsy
  • Liquid Trace® Overview
  • Liquid Trace® Solid Tumor
  • Liquid Trace® Hematology
Solid Tumors
  • Solid Tumor Profile Plus
  • IHC Testing
  • Solid Tumor Profile
  • Solid Tumor Fusion/Expression Profile
  • Liquid Trace® Solid Tumor
Hematologic Tumors
  • Hematology Profile Plus
  • Hematology Profile
  • Liquid Trace® Hematology

Physicians

  • Why GTC
  • What Cancers We Test for
  • Cooperative Model
  • Co-Op Members
  • NGS Testing
  • AI - Machine Learning
  • Turnaround Time (TAT)
  • Cancer Disparity Program
  • Publications
  • FAQ for Physicians
Gene Tables
  • Solid Tumor DNA Genes
  • Hematology DNA Genes
  • cfDNA Genes
  • RNA & cfRNA Genes

Patients

  • Why Testing Matters
  • Time Matters
  • Reducing Cancer Disparity
  • Non-Invasive Liquid Biopsy
  • What Test to Order
  • Patient Foundations
  • What is VEXAS
  • FAQ for Patients
Research
  • Pharma and Research Services
  • Digital Molecular Sample Bank  
  • Biomarker Data
  • Gene Expression
  • CDx – Companion Diagnostics
  • Schedule a Consult

About GTC

  • Client Services
  • Our Story
  • Our Team
  • Licenses & Certifications
  • The Co-Op in Action
  • International Representatives
  • Careers
  • Events
  • Investors
  • Media Kit
  • Contact Us
Newsroom
  • Press Releases
  • Publications
  • Events
  • Blog | Articles
  • Newsletter Subscription
  • Downloads

Call Us: 866-484-8870

Follow Us

Linkedin Twitter Facebook Youtube

Contact Us

Genomic Testing Cooperative Logo
  • Genomic Tests
    • Genomic Testing Overview
    • Liquid Trace®
      • Liquid Trace® Solid Tumor
      • Liquid Trace® Hematology
      • Liquid Trace® Overview
    • Solid Tumors
      • Solid Tumor Profile Plus
      • IHC Testing
      • Solid Tumor Profile
      • Solid Tumor Fusion/Expression Profile
      • Liquid Trace® Solid Tumor
    • Hematologic Tumors
      • Hematology Profile Plus
      • Hematology Profile
      • Liquid Trace® Hematology
    • Gene Tables
      • Solid Tumor DNA Genes
      • Hematology DNA Genes
      • cfDNA Genes
      • RNA & cfRNA Genes
    • What Test to Order
    • How to Order a Test
  • Physicians
    • Why GTC
    • What cancers do we test for
    • Cooperative Model
    • NGS Testing
    • AI – Machine Learning
    • Turnaround Time – TAT
    • Reducing Cancer Disparity Program
    • Publications
    • Physicians Billing
    • FAQ for Physicians
  • Patients
    • Why Testing Matters
    • Time Matters
    • Reducing Cancer Disparity Program
    • Non-Invasive Liquid Biopsy
    • What Test to Order
    • Patient Foundations
    • What is VEXAS Disease?
    • Physicians Billing
    • FAQ for Patients
  • About Us
    • Client Services
    • Our Story
    • Our Team
    • CGMBS Training
    • Licenses and Certifications
    • Cooperative Model
      • How the Coop Works
      • The Coop in Action
    • International Representatives
    • Careers
    • Events
    • Investors
    • Media Kit
    • Contact Us
  • Research
    • Research & Pharma Services
    • Digital Molecular Sample Bank  
    • Biomarker Data
    • CDx – Companion Diagnostics
    •   Schedule a Consult  
  • Newsroom
    • Press Releases
    • Publications
    • Events
    • Blog / Articles
    • Newsletter Subscription
    • Downloads
  • Patients Results
  • Genomic Tests
    • Genomic Testing Overview
    • Liquid Trace®
      • Liquid Trace® Solid Tumor
      • Liquid Trace® Hematology
      • Liquid Trace® Overview
    • Solid Tumors
      • Solid Tumor Profile Plus
      • IHC Testing
      • Solid Tumor Profile
      • Solid Tumor Fusion/Expression Profile
      • Liquid Trace® Solid Tumor
    • Hematologic Tumors
      • Hematology Profile Plus
      • Hematology Profile
      • Liquid Trace® Hematology
    • Gene Tables
      • Solid Tumor DNA Genes
      • Hematology DNA Genes
      • cfDNA Genes
      • RNA & cfRNA Genes
    • What Test to Order
    • How to Order a Test
  • Physicians
    • Why GTC
    • What cancers do we test for
    • Cooperative Model
    • NGS Testing
    • AI – Machine Learning
    • Turnaround Time – TAT
    • Reducing Cancer Disparity Program
    • Publications
    • Physicians Billing
    • FAQ for Physicians
  • Patients
    • Why Testing Matters
    • Time Matters
    • Reducing Cancer Disparity Program
    • Non-Invasive Liquid Biopsy
    • What Test to Order
    • Patient Foundations
    • What is VEXAS Disease?
    • Physicians Billing
    • FAQ for Patients
  • About Us
    • Client Services
    • Our Story
    • Our Team
    • CGMBS Training
    • Licenses and Certifications
    • Cooperative Model
      • How the Coop Works
      • The Coop in Action
    • International Representatives
    • Careers
    • Events
    • Investors
    • Media Kit
    • Contact Us
  • Research
    • Research & Pharma Services
    • Digital Molecular Sample Bank  
    • Biomarker Data
    • CDx – Companion Diagnostics
    •   Schedule a Consult  
  • Newsroom
    • Press Releases
    • Publications
    • Events
    • Blog / Articles
    • Newsletter Subscription
    • Downloads
  • Patients Results
Hackensack Meridian Health Partners with Genomic Testing Cooperative to Establish a Reference Laboratory Offering State-of-the-Art Genomic Precision Testing
Article

Hackensack Meridian Health Partners with GTC to Establish a Reference Laboratory Offering State-of-the-Art Genomic Precision Testing

IRVINE, Calif. and EDISON, N.J., July 22, 2020 /PRNewswire/ — Hackensack Meridian Health (HMH) in Edison, New Jersey, and Genomic Testing Cooperative (GTC), Irvine, California, announced

Read More »
July 22, 2020 4:00 am
John Theurer Cancer Center and GTC
Genomics

John Theurer Cancer Center/RCCA collaborate with GTC to internalize proprietary NGS DNA and RNA testing

John Theurer Cancer Center to Establish Next Generation Sequencing Laboratory for Precision Genomic Profiling of Cancers, Adapting Testing Developed for DNA and RNA IRVINE, Calif.

Read More »
May 27, 2020 4:00 am
GTC research is being presented at ASCO 2020
Press Releases

GTC research is being presented at ASCO 2020

GTC research is being presented at ASCO 2020 in the following three abstracts. 1. FGFR expression, fusion and mutation as detected by NGS sequencing of

Read More »
May 20, 2020 9:50 am
GTC featured in the Orange County Business Journal
Genomics

GTC was featured in the Orange County Business Journal again

  GTC featured in the Orange County Business Journal on February 3, 2020  

Read More »
February 26, 2020 11:00 am
Genomic Testing Cooperative New Collaboration to Offer Liquid Biopsy Testing
Press Releases

New Collaboration to Offer Liquid Biopsy Testing

Genomic Testing Cooperative (GTC) and C2i Genomics Announce Collaboration to Offer Liquid Biopsy Testing for Staging and Monitoring Solid Tumors Based on Pattern Recognition of

Read More »
January 14, 2020 4:00 am
Genomic Testing Cooperative Receives Medicare Coverage for GTC-Solid Tumor Profile (434 gene) Test
Press Releases

Genomic Testing Cooperative (GTC) Receives Medicare (Palmetto GBA) Coverage for GTC-Solid Tumor Profile (434 gene) Test

GTC Solid Tumor Profile™ with 434 genes test is now covered by Medicare for patients with a wide range of solid tumor cancers Irvine, California–

Read More »
January 7, 2020 4:00 am
American Society of Hematology Meeting: PRESENTATION POSTERS
Press Releases

American Society of Hematology Meeting 2019: PRESENTATION POSTERS

            (Click photo to download the pdf file)  

Read More »
December 12, 2019 10:51 am
Genomic Testing Cooperative to Present at American Society of Hematology Annual Meeting 2019
Press Releases

Genomic Testing Cooperative to Present at American Society of Hematology Annual Meeting 2019

Genomic Testing Cooperative to Present Data on its Proprietary RNA Profiling and Artificial Intelligence Algorithms at American Society of Hematology Annual Meeting Irvine, California– December

Read More »
December 3, 2019 4:59 am
GTC featured in the Orange County Business Journal
Genomics

GTC was honored to be featured in the Orange County Business Journal

  GTC featured in the Orange County Business Journal on September 30, 2019 [Click image to enlarge]  

Read More »
October 16, 2019 10:24 am
DNA RNA ALL
Innovation

Do not Accept partial results about PH-Like Acute Lymphoblastic Leukemia

Distinguishing PH-like acute lymphoblastic leukemia (ALL) from other types of ALL relies on full evaluation of the molecular abnormalities in the leukemic cells. Order GTC

Read More »
October 1, 2019 10:16 pm
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Next »

We are a cooperative-based clinical laboratory using state-of-the-art innovation in next generation sequencing and machine/deep learning

866-484-8870

CUSTOMER SUPPORT

949-301-9719

SEND YOUR FAX

About GTC

  • Our Story
  • Our Team
  • Co-Op Model
  • Licenses
  • Careers
  • Events
  • Newsroom
  • Contact Us

Physicians

  • Why GTC
  • Tests Overview
  • Gene Tables
  • NGS Testing
  • Machine Learning
  • Disparity Program
  • Downloads
  • FAQ

Patients

  • Why Testing Matters
  • Time Matters
  • Non-Invasive Biopsy
  • What Test to Order
  • Patient Foundations
  • What is VEXAS
  • FAQ

Downloads

Test Requisition
User Guide
Account Setup Form
Sample Reports
Brochures

Follow Us

Facebook-f X-twitter Linkedin Youtube
Licensing
UK Reponsible Person & EU Authorized Representative

38 Queen Street, Glasgow, G1 3DX, Scotland

  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms & Conditions
  • Licensing
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms & Conditions
  • Licensing

© All rights reserved Genomic Testing Cooperative.

Handcrafted by Digital Heroes

We are a cooperative-based clinical laboratory using state-of-the-art innovation in next generation sequencing and machine/deep learning

866-484-8870

CUSTOMER SUPPORT

949-301-9719

SEND YOUR FAX

Follow Us

Facebook-f Twitter Linkedin Youtube
Licensing
UK Reponsible Person & EU Authorized Representative

Quinckestrasse. 46 | 69120 Heidelberg Germany

  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms & Conditions
  • Licensing
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms & Conditions
  • Licensing

© All rights reserved Genomic Testing Cooperative.

Handicrafted by Digital Heroes

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. You can customize your preferences from Cookie Settings. Read GTC's Privacy Policy
We do not sell your personal information.
Cookie settingsREJECTACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT